SCHEMBL26325920

SCHEMBL26325920

CCc1ccc(CN)c(Cl)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A1 P68400 7/20 0.49
CSNK2A2 P19784 1/20 0.49
CSNK2B P67870 1/20 0.49
CSNK2A3 Q8NEV1 1/20 0.49
PNMT P11086 4/20 0.45
TAAR1 Q96RJ0 2/20 0.41
LMNA P02545 1/20 0.40
MAPK1 P28482 1/20 0.40
NLRP1 Q9C000 1/20 0.40
TRPA1 O75762 1/20 0.39
CYP3A4 P08684 1/20 0.38
HTR1A P08908 1/20 0.38
HTR1D P28221 1/20 0.38
HTR1B P28222 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2A6 P11509 1/20 0.38
GLA P06280 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
DPP4 P27487 1/20 0.35
NOS3 P29474 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2602714 0.85 LMNA (0.46) CSNK2A1CSNK2A2CSNK2BCSNK2A3PNMT
SCHEMBL2006591 0.85 CSNK2A1 (0.52) CSNK2A1CSNK2A2CSNK2BCSNK2A3PNMT
SCHEMBL5138176 0.83 CSNK2A1 (0.62) CSNK2A1CSNK2A2CSNK2BCSNK2A3PNMT
SCHEMBL28098160 0.80 TAAR1 (0.44) CSNK2A1CSNK2A2CSNK2BCSNK2A3TAAR1
SCHEMBL12763604 0.79 MAPK1 (0.40) CSNK2A1CSNK2A2CSNK2BCSNK2A3PNMT
SCHEMBL8772771 0.79 TRPA1 (0.43) CSNK2A1CSNK2A2CSNK2BCSNK2A3LMNA
SCHEMBL15591097 0.78 BACE1 (0.46) CSNK2A1CSNK2A2CSNK2BCSNK2A3TAAR1
SCHEMBL10732579 0.78 BACE1 (0.46) CSNK2A1CSNK2A2CSNK2BCSNK2A3TAAR1
SCHEMBL23442587 0.77 TAAR1 (0.41) CSNK2A1CSNK2A2CSNK2BCSNK2A3TAAR1
SCHEMBL14183918 0.77 TAAR1 (0.41) CSNK2A1CSNK2A2CSNK2BCSNK2A3TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4234552-A2 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF Raze Therapeutics, Inc. (US) 2023-08-30 EP disclosed